Stacy L ChinFounder, KeepYourEquity · I get the government to write you checks

Top 3 Biotech Trends: Where Government Funding Goes 2026

13 Feb 2026 · 1 min

Watch on YouTube

1:12

In this video, Stacy Chin addresses biotech founders during a period when venture capital funding has slowed dramatically, but federal agencies such as the NIH, ARPA, and the Department of Defense continue to pour money into the sector. She promises to outline the three most important biotech trends for 2026 and explain exactly where these agencies are directing their investments. The goal is to help early‑stage, scrappy innovators position their companies to win non‑dilutive capital—funding that requires no equity, board seats, or dilution. By understanding the federal funding landscape and the specific priorities of each agency, founders can align their technology roadmaps and applications to capture this government money before the competition catches up.

Chapters

While venture money froze, the government kept spending in this sector. So if you wanna know where the money's headed so that you can align your startup strategy now, stick around to this video and let's dive in, cuz I'm gonna walk you through the top 3 biotech trends of 2026, and I'm gonna tell you where I think NIH, ARPA, and DOD are investing next so that you can best position your startup and innovation to win. If you're a biotech founder, especially right now, you need to hear this. While those venture markets slowed down, the federal markets and funding initiatives have not. And the smartest founders I know, they're not only just chasing investors right now, but they're also going after non-dilutive capital. And because this is really what non-dilutive really means—no equity given up, no board seats, and no dilutions. Because right now the government's looking hard for early-stage teams, the scrappy innovators that can solve big and real national-wide problems. Because these federal agencies like NIH, ARPA, HMDOD are already shaping the 2026 priorities. So in this video, I'm going to I'm going to walk you through what that exactly means in addition to what reviews are prioritizing, that how you can best position your startup to win non-dilutive funding before everyone else catches up to it.